Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
about
CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.Gga-miR-101-3p Plays a Key Role in Mycoplasma gallisepticum (HS Strain) Infection of Chicken.Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer.Regulatory variation: an emerging vantage point for cancer biology.LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2.MicroRNAs and drug resistance in prostate cancers.miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence.EZH2 is overexpressed in laryngeal squamous cell carcinoma and enhances the stem-like properties of AMC-HN-8 cells.Reversing epigenetic mechanisms of drug resistance in solid tumors using targeted microRNA delivery.RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancerEpigenetic regulation of cancer biology and anti-tumor immunity by EZH2.Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis.The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes.Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells.MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells.
P2860
Q34487797-9C27E4CE-2883-4399-9FE6-5D8FE8ED5188Q34541700-1E1E864B-F45A-4B3C-8935-B05CAFFF2A8EQ35854018-7FBDD3DD-8469-4930-AAF9-A4513C32FB92Q36349927-7FF78E16-92B0-443E-A255-B938354185CFQ36404054-22A55CAF-AE29-4FA5-BDA9-28A14C3D1764Q36440631-1EFD615C-CE12-494A-B4CF-B7039F74C844Q38164307-1ABAA3F7-F7A7-453D-A1DB-52E49F40252AQ38176848-013163E0-122A-4F26-B907-492859672CB5Q38205266-38382D6B-FFF8-4BC5-A673-FE4A9CEB86C7Q38411340-D6754F88-7FA8-4FDD-A31D-68C6D7B3DA1FQ38756492-CB689F4D-07DA-4D2F-84A6-3B9BEDA0D24DQ38812898-E4F4283D-E14A-4EC7-80D0-F075F9A126C6Q38925687-592AE18A-1EC5-4C2E-8E6E-6545BD125D73Q38993869-F31D9CEC-9649-400E-9DA8-7C6C6B3343EBQ39424549-BB0EB317-8861-4B5B-89B1-578EFA43A9B3Q42090074-199F9B6A-9E19-4244-9194-2B40DC31ED08Q50954236-58F5340F-FBA1-4619-8CE4-A1327181E31FQ51516890-49430DE9-FDEC-4BCE-961E-8044B4BE10EBQ54256847-65EA160A-EEBD-4B0A-B297-3B03D59CF155Q54321491-48A6E296-09D1-4885-991C-AB09822CE6BA
P2860
Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
@en
Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
@nl
type
label
Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
@en
Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
@nl
prefLabel
Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
@en
Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
@nl
P2093
P2860
P356
P1476
Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
@en
P2093
Bangfen Zhou
Kuiqing Li
Liangkuan Bi
Tianxin Lin
P2860
P304
11981-11993
P356
10.3390/IJMS140611981
P407
P577
2013-06-05T00:00:00Z